查找临床试验
已按「1型糖尿病」检索，对应国际通用词 type 1 diabetes
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 10:14，每 5 分钟自动同步Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus
China
年龄 18 Years – 60 Years
Hangzhou Reprogenix Bioscience, Inc
AI-Assisted Remote Insulin Pump Optimization in T1DM
China
年龄 14 Years – 65 Years
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission
China
年龄 18 Years – 65 Years
Beijing Friendship Hospital
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
China
年龄 不限 – 18 Years
Children's Hospital of Fudan University
Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research
China
年龄 不限 – 不限
Second Xiangya Hospital of Central South University
Intervention for Children With Type 1 Diabetes Targeting Gut Microbes
China
年龄 6 Years – 12 Years
Children's Hospital of Fudan University
AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
China
年龄 18 Years – 75 Years
Fudan University
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
United States、Argentina、Australia、Brazil、Bulgaria 等 12 国
年龄 18 Years – 不限
AstraZeneca
A Food-Effect Study of CX11 in Healthy Participants
China
年龄 18 Years – 45 Years
Vincentage Pharma Co., Ltd
Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus
China
年龄 18 Years – 65 Years
Nanjing Medical University
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
China
年龄 不限 – 不限
Second Xiangya Hospital of Central South University
Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes
China
年龄 4 Years – 不限
Peking University First Hospital